APA

Woan K. V., Lienlaf M., Perez-Villaroel P., Lee C., Cheng F., Knox T., Woods D. M., Barrios K., Powers J., Sahakian E., Wang H. W., Canales J., Marante D., Smalley K. S. M., Bergman J., Seto E., Kozikowski A., Pinilla-Ibarz J., Sarnaik A., Celis E., Weber J., Sotomayor E. M. & Villagra A. (20160603). Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. : Molecular oncology.

Chicago

Woan K V, Lienlaf M, Perez-Villaroel P, Lee C, Cheng F, Knox T, Woods D M, Barrios K, Powers J, Sahakian E, Wang H W, Canales J, Marante D, Smalley K S M, Bergman J, Seto E, Kozikowski A, Pinilla-Ibarz J, Sarnaik A, Celis E, Weber J, Sotomayor E M and Villagra A. 20160603. Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. : Molecular oncology.

Harvard

Woan K. V., Lienlaf M., Perez-Villaroel P., Lee C., Cheng F., Knox T., Woods D. M., Barrios K., Powers J., Sahakian E., Wang H. W., Canales J., Marante D., Smalley K. S. M., Bergman J., Seto E., Kozikowski A., Pinilla-Ibarz J., Sarnaik A., Celis E., Weber J., Sotomayor E. M. and Villagra A. (20160603). Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. : Molecular oncology.

MLA

Woan K V, Lienlaf M, Perez-Villaroel P, Lee C, Cheng F, Knox T, Woods D M, Barrios K, Powers J, Sahakian E, Wang H W, Canales J, Marante D, Smalley K S M, Bergman J, Seto E, Kozikowski A, Pinilla-Ibarz J, Sarnaik A, Celis E, Weber J, Sotomayor E M and Villagra A. Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. : Molecular oncology. 20160603.